Strain-dependent activity of Zika virus and exposure history in serological diagnostics
Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serologic...
Saved in:
| Published in | Tropical medicine and infectious disease Vol. 5; no. 1; pp. 1 - 14 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
MDPI AG
01.03.2020
MDPI |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2414-6366 2414-6366 |
| DOI | 10.3390/tropicalmed5010038 |
Cover
Loading…
| Abstract | Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR-766, PRVABC59, and R103454). Here, MR-766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 (p = 0.008). ZKA185 enhanced dengue 4 infection up to 50% (p = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR-766 and R103453 were inhibited up to 90% (p = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR-766 30%-40% better than PRVABC56 or R103454 (p = 0.005-0.00007). The most troubling finding was the significant neutralization of MR-766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses. |
|---|---|
| AbstractList | Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR-766, PRVABC59, and R103454). Here, MR-766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 (p = 0.008). ZKA185 enhanced dengue 4 infection up to 50% (p = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR-766 and R103453 were inhibited up to 90% (p = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR-766 ~30%-40% better than PRVABC56 or R103454 (p = 0.005-0.00007). The most troubling finding was the significant neutralization of MR-766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses. Keywords: Zika virus; flavivirus; cross-reactivity; neutralization; diagnostics; serology; plaque reduction neutralization test; flavivirus exposure Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR-766, PRVABC59, and R103454). Here, MR-766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 (p = 0.008). ZKA185 enhanced dengue 4 infection up to 50% (p = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR-766 and R103453 were inhibited up to 90% (p = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR-766 ~30%-40% better than PRVABC56 or R103454 (p = 0.005-0.00007). The most troubling finding was the significant neutralization of MR-766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses.Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR-766, PRVABC59, and R103454). Here, MR-766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 (p = 0.008). ZKA185 enhanced dengue 4 infection up to 50% (p = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR-766 and R103453 were inhibited up to 90% (p = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR-766 ~30%-40% better than PRVABC56 or R103454 (p = 0.005-0.00007). The most troubling finding was the significant neutralization of MR-766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses. Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR-766, PRVABC59, and R103454). Here, MR-766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 ( = 0.008). ZKA185 enhanced dengue 4 infection up to 50% ( = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR-766 and R103453 were inhibited up to 90% ( = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR-766 ~30%-40% better than PRVABC56 or R103454 ( = 0.005-0.00007). The most troubling finding was the significant neutralization of MR-766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses. Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR−766, PRVABC59, and R103454). Here, MR−766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 ( p = 0.008). ZKA185 enhanced dengue 4 infection up to 50% ( p = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR−766 and R103453 were inhibited up to 90% ( p = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR−766 ~30%−40% better than PRVABC56 or R103454 ( p = 0.005−0.00007). The most troubling finding was the significant neutralization of MR−766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses. Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR−766, PRVABC59, and R103454). Here, MR−766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 (p = 0.008). ZKA185 enhanced dengue 4 infection up to 50% (p = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR−766 and R103453 were inhibited up to 90% (p = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR−766 ~30%−40% better than PRVABC56 or R103454 (p = 0.005−0.00007). The most troubling finding was the significant neutralization of MR−766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses. Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR-766, PRVABC59, and R103454). Here, MR-766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 (p = 0.008). ZKA185 enhanced dengue 4 infection up to 50% (p = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR-766 and R103453 were inhibited up to 90% (p = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR-766 ~30%-40% better than PRVABC56 or R103454 (p = 0.005-0.00007). The most troubling finding was the significant neutralization of MR-766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses. |
| Audience | Academic |
| Author | Kelli L Barr Erum Khan Ruiyu Pu Kehkashan Imtiaz JGlenn Morris Maureen T Long Erika R Schwarz Dhani Prakoso |
| AuthorAffiliation | 2 Department of Comparative Diagnostic and Population Medicine, College of Veterinary Medicine, University of Florida, Gainesville, FL 32608, USA; eschwarz@ufl.edu (E.R.S.); dprakoso@ufl.edu (D.P.); pur@ufl.edu (R.P.); longm@ufl.edu (M.T.L.) 3 Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi 74800, Pakistan; kehkashan.imtiaz@aku.edu (K.I.); erum.khan@aku.edu (E.K.) 1 Department of Biology, Baylor University, Waco, TX 76798, USA 4 Emerging Pathogens Institute, University of Florida, Gainesville, FL 32601, USA; JGMorris@epi.ufl.edu |
| AuthorAffiliation_xml | – name: 3 Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi 74800, Pakistan; kehkashan.imtiaz@aku.edu (K.I.); erum.khan@aku.edu (E.K.) – name: 2 Department of Comparative Diagnostic and Population Medicine, College of Veterinary Medicine, University of Florida, Gainesville, FL 32608, USA; eschwarz@ufl.edu (E.R.S.); dprakoso@ufl.edu (D.P.); pur@ufl.edu (R.P.); longm@ufl.edu (M.T.L.) – name: 4 Emerging Pathogens Institute, University of Florida, Gainesville, FL 32601, USA; JGMorris@epi.ufl.edu – name: 1 Department of Biology, Baylor University, Waco, TX 76798, USA |
| Author_xml | – sequence: 1 givenname: Kelli L. orcidid: 0000-0001-7943-7181 surname: Barr fullname: Barr, Kelli L. – sequence: 2 givenname: Erika R. orcidid: 0000-0002-6641-6063 surname: Schwarz fullname: Schwarz, Erika R. – sequence: 3 givenname: Dhani orcidid: 0000-0001-9071-5381 surname: Prakoso fullname: Prakoso, Dhani – sequence: 4 givenname: Kehkashan surname: Imtiaz fullname: Imtiaz, Kehkashan – sequence: 5 givenname: Ruiyu surname: Pu fullname: Pu, Ruiyu – sequence: 6 givenname: J. Glenn orcidid: 0000-0001-9347-1984 surname: Morris fullname: Morris, J. Glenn – sequence: 7 givenname: Erum surname: Khan fullname: Khan, Erum – sequence: 8 givenname: Maureen T. orcidid: 0000-0001-5337-9024 surname: Long fullname: Long, Maureen T. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32138262$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kl1rFDEUhgep2Fr7B7yQAW96M_VMPicgQil-FApeqAjehEw-tllnJ2uSXdx_b2anlq6K5CIhed6X95ycp9XRGEZbVc9buMBYwKscw9prNaysodAC4O5RdYJISxqGGTt6cD6uzlJaAkDbUWAEnlTHGLW4QwydVF8_5aj82Bi7tqOxY66Vzn7r864Orv7mv6t66-Mm1Wo0tf25DmkTbX3rUw5xV_uxTjaGISymKLXxajGGlL1Oz6rHTg3Jnt3tp9WXd28_X31obj6-v766vGk07brcOEwwcZQK2mMNGPfY9shyZYRxwLGzjnBODMIac9b3AlHnNKWKAbWiFwqfVtezrwlqKdfRr1TcyaC83F-EuJAqlkCDlYI6cKblVvWYcNMLQjB1AlOFemT45PVm9lpv-tJWXboR1XBgevgy-lu5CFvJW8oZh2JwfmcQw4-NTVmufNJ2GNRowyZJhHkpFzqY0JczulAlmh9dKI56wuUlQ50gHCgp1MU_qLKMXXldBsL5cn8gePGwhPvsvz-8AGgGdAwpRevukRbkNFjy78Eqou4PkfZZZR-mNvjh_9LXszSufJY6DIPVkzAtVU6zsGX7yvYAdEhQAsAY44J2-BeP1utN |
| CitedBy_id | crossref_primary_10_3390_vaccines8040752 crossref_primary_10_3389_fpubh_2020_00287 |
| Cites_doi | 10.4269/ajtmh.2011.10-0439 10.1051/vetres/2009026 10.1016/j.jviromet.2018.10.011 10.3201/eid1408.080287 10.1128/JVI.01049-17 10.15585/mmwr.mm6629e1 10.3201/eid2305.161631 10.3201/eid2205.160065 10.1128/JVI.00273-15 10.3390/vaccines7020055 10.1371/journal.pone.0117849 10.1038/ni.3058 10.3201/eid2507.182000 10.1016/0035-9203(52)90042-4 10.1186/1743-422X-7-28 10.3389/fpubh.2016.00008 10.1002/jmv.25504 10.1073/pnas.1704984114 10.1016/j.chom.2010.08.007 10.1371/journal.ppat.1002930 10.1056/NEJMra1602113 10.1128/CMR.00072-15 10.4269/ajtmh.1985.34.162 10.1128/microbiolspec.AID-0022-2014 10.3201/eid1509.090442 10.1126/science.aah6187 10.1128/JVI.00405-19 10.1002/jmv.24735 10.3201/eid2410.180360 10.1371/journal.pntd.0007162 10.1111/trf.14026 10.1093/trstmh/trz077 10.1128/JCM.00279-16 10.1038/nature18938 10.4269/ajtmh.18-0755 10.2147/VAAT.S36856 10.1371/journal.pntd.0000721 10.1371/journal.pntd.0005554 10.1007/s00705-006-0903-z 10.1016/j.chom.2010.02.004 10.1017/S0022172400025997 10.1016/j.celrep.2016.07.049 10.15585/mmwr.rr6801a1 10.1016/j.cell.2017.09.002 10.1126/science.aaf8505 10.1016/j.ymthe.2019.03.005 10.1089/vbz.2005.5.137 10.1111/1469-0691.12075 10.1016/j.jinf.2017.05.021 10.1038/s41467-018-03772-1 10.4269/ajtmh.1982.31.830 10.1002/rmv.405 10.1093/infdis/jiy164 10.1099/0022-1317-70-1-37 10.3201/eid1909.130377 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2020 MDPI AG 2020 by the authors. 2020 |
| Copyright_xml | – notice: COPYRIGHT 2020 MDPI AG – notice: 2020 by the authors. 2020 |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3390/tropicalmed5010038 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2414-6366 |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_95f0fd17eab347db94435f935a2b2d7a PMC7157670 A628947054 32138262 10_3390_tropicalmed5010038 10.3316/informit.082954006667958 |
| Genre | Journal Article |
| GeographicLocations | Pakistan |
| GeographicLocations_xml | – name: Pakistan |
| GrantInformation_xml | – fundername: Florida Department of Health grantid: 7ZK12 – fundername: Defense Threat Reduction Agency grantid: HDRTA1-14-1-0022 – fundername: Horizon 2020 grantid: 734857 |
| GroupedDBID | 53G 7X7 AADQD AAFWJ ADBBV AFPKN AFZYC AH1 ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV GROUPED_DOAJ HYE IAEEK IAO IHR ITC MODMG M~E OK1 PGMZT RPM AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c588t-f3434f5595b3c033b3eb2e7ad9df073fef4774d23c376bb925ffc55a605e9b9a3 |
| IEDL.DBID | DOA |
| ISSN | 2414-6366 |
| IngestDate | Wed Aug 27 01:28:46 EDT 2025 Thu Aug 21 18:20:20 EDT 2025 Thu Jul 10 19:32:17 EDT 2025 Wed Mar 19 01:25:52 EDT 2025 Sat Mar 08 17:45:39 EST 2025 Thu Jan 02 22:59:39 EST 2025 Fri Jul 18 18:28:07 EDT 2025 Thu Apr 24 22:56:23 EDT 2025 Wed Jan 29 00:05:30 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | diagnostics neutralization flavivirus exposure serology plaque reduction neutralization test Zika virus cross-reactivity flavivirus |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c588t-f3434f5595b3c033b3eb2e7ad9df073fef4774d23c376bb925ffc55a605e9b9a3 |
| Notes | Tropical Medicine and Infectious Disease, Vol. 5, No. 1, Mar 2020: 1-14 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-6641-6063 0000-0001-7943-7181 0000-0001-9071-5381 0000-0001-9347-1984 0000-0001-5337-9024 |
| OpenAccessLink | https://doaj.org/article/95f0fd17eab347db94435f935a2b2d7a |
| PMID | 32138262 |
| PQID | 2374340800 |
| PQPubID | 23479 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_95f0fd17eab347db94435f935a2b2d7a pubmedcentral_primary_oai_pubmedcentral_nih_gov_7157670 proquest_miscellaneous_2374340800 gale_infotracmisc_A628947054 gale_infotracacademiconefile_A628947054 pubmed_primary_32138262 crossref_primary_10_3390_tropicalmed5010038 crossref_citationtrail_10_3390_tropicalmed5010038 rmit_collectionsjats_10_3316_informit_082954006667958 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-03-01 |
| PublicationDateYYYYMMDD | 2020-03-01 |
| PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Tropical medicine and infectious disease |
| PublicationTitleAlternate | Trop Med Infect Dis |
| PublicationYear | 2020 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Barr (ref_29) 2012; 4 Dick (ref_20) 1952; 46 ref_14 Brault (ref_30) 2011; 85 Lanciotti (ref_6) 2008; 14 Speer (ref_1) 2016; 353 Stettler (ref_33) 2016; 353 Esquivel (ref_23) 2019; 27 Voermans (ref_52) 2019; 25 Rossini (ref_54) 2017; 75 Montoya (ref_51) 2018; 218 Filippone (ref_16) 2013; 19 ref_60 Johnson (ref_15) 2005; 5 ref_24 ref_22 Chao (ref_10) 2018; 57 Gorchakov (ref_3) 2019; 100 Brault (ref_41) 2009; 40 ref_27 ref_26 Barr (ref_43) 2013; 5 Jaaskelainen (ref_11) 2019; 263 Calisher (ref_12) 1989; 70 Waggoner (ref_2) 2016; 54 Santiago (ref_25) 2018; 9 Sharp (ref_47) 2019; 68 ref_32 Baylis (ref_56) 2017; 57 Schieffelin (ref_61) 2010; 7 Takada (ref_38) 2003; 13 Hayes (ref_17) 2009; 15 Musso (ref_5) 2017; 89 ref_37 Dejnirattisai (ref_35) 2015; 16 Tsai (ref_13) 2015; 89 Kuno (ref_18) 2007; 152 Lanciotti (ref_21) 2016; 22 Mann (ref_28) 2013; 19 Henchal (ref_36) 1982; 31 Dejnirattisai (ref_44) 2016; 536 Oduyebo (ref_7) 2017; 66 ref_45 Fagbami (ref_19) 1979; 83 Wang (ref_58) 2017; 171 ref_40 Venturi (ref_49) 2019; 91 Kisuya (ref_50) 2019; 113 Beltramello (ref_34) 2010; 8 Henchal (ref_57) 1985; 34 Dowd (ref_46) 2016; 16 Mansuy (ref_53) 2017; 23 Khan (ref_59) 2016; 4 ref_48 ref_9 ref_8 Musso (ref_42) 2016; 29 Pierson (ref_39) 2010; 7 Baylis (ref_55) 2018; 24 Petersen (ref_4) 2016; 374 Balmaseda (ref_31) 2017; 114 |
| References_xml | – volume: 85 start-page: 758 year: 2011 ident: ref_30 article-title: Reduced Avian Virulence and Viremia of West Nile Virus Isolates from Mexico and Texas 23 publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.2011.10-0439 – volume: 40 start-page: 1 year: 2009 ident: ref_41 article-title: Changing patterns of West Nile virus transmission: Altered vector competence and host susceptibility publication-title: Vet. Res. doi: 10.1051/vetres/2009026 – ident: ref_9 – volume: 263 start-page: 68 year: 2019 ident: ref_11 article-title: Validation of serological and molecular methods for diagnosis of zika virus infections publication-title: J. Virol. Methods doi: 10.1016/j.jviromet.2018.10.011 – volume: 14 start-page: 1232 year: 2008 ident: ref_6 article-title: Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1408.080287 – ident: ref_32 doi: 10.1128/JVI.01049-17 – volume: 66 start-page: 781 year: 2017 ident: ref_7 article-title: Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure—United States (Including U.S. Territories), July 2017 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm6629e1 – ident: ref_26 – volume: 23 start-page: 863 year: 2017 ident: ref_53 article-title: Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2305.161631 – volume: 22 start-page: 933 year: 2016 ident: ref_21 article-title: Phylogeny of Zika Virus in Western Hemisphere, 2015 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2205.160065 – volume: 89 start-page: 7348 year: 2015 ident: ref_13 article-title: Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies publication-title: J. Virol. doi: 10.1128/JVI.00273-15 – ident: ref_24 doi: 10.3390/vaccines7020055 – ident: ref_40 doi: 10.1371/journal.pone.0117849 – volume: 16 start-page: 170 year: 2015 ident: ref_35 article-title: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus publication-title: Nat. Immunol. doi: 10.1038/ni.3058 – volume: 25 start-page: 1394 year: 2019 ident: ref_52 article-title: Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in Routine Diagnostic Setting publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2507.182000 – volume: 46 start-page: 509 year: 1952 ident: ref_20 article-title: Zika virus I. Isolations and serological specificity publication-title: Trans. R. Soc. Trop. Med. Hyg. doi: 10.1016/0035-9203(52)90042-4 – ident: ref_8 – volume: 7 start-page: 28 year: 2010 ident: ref_61 article-title: Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient publication-title: Virol. J. doi: 10.1186/1743-422X-7-28 – ident: ref_27 – volume: 4 start-page: 8 year: 2016 ident: ref_59 article-title: Flaviviruses as a Cause of Undifferentiated Fever in Sindh Province, Pakistan: A Preliminary Report publication-title: Front. Public Health doi: 10.3389/fpubh.2016.00008 – volume: 91 start-page: 1577 year: 2019 ident: ref_49 article-title: Epidemiological and clinical suspicion of congenital Zika virus infection: Serological findings in mothers and children from Brazil publication-title: J. Med. Virol. doi: 10.1002/jmv.25504 – volume: 114 start-page: 8384 year: 2017 ident: ref_31 article-title: Antibody-based assay discriminates Zika virus infection from other flaviviruses publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1704984114 – volume: 8 start-page: 271 year: 2010 ident: ref_34 article-title: The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity publication-title: Cell Host Microbe doi: 10.1016/j.chom.2010.08.007 – ident: ref_45 doi: 10.1371/journal.ppat.1002930 – volume: 374 start-page: 1552 year: 2016 ident: ref_4 article-title: Zika Virus publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1602113 – volume: 29 start-page: 487 year: 2016 ident: ref_42 article-title: Zika Virus publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.00072-15 – volume: 34 start-page: 162 year: 1985 ident: ref_57 article-title: Epitopic analysis of antigenic determinants on the surface of dengue−2 virions using monoclonal antibodies publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.1985.34.162 – ident: ref_37 doi: 10.1128/microbiolspec.AID-0022-2014 – volume: 15 start-page: 1347 year: 2009 ident: ref_17 article-title: Zika virus outside Africa publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1509.090442 – volume: 353 start-page: 750 year: 2016 ident: ref_1 article-title: Diagnostics for Zika virus on the horizon publication-title: Science doi: 10.1126/science.aah6187 – ident: ref_22 doi: 10.1128/JVI.00405-19 – volume: 89 start-page: 1505 year: 2017 ident: ref_5 article-title: Molecular detection of Zika virus in blood and RNA load determination during the French Polynesian outbreak publication-title: J. Med. Virol. doi: 10.1002/jmv.24735 – volume: 24 start-page: 1966 year: 2018 ident: ref_55 article-title: External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2410.180360 – ident: ref_48 doi: 10.1371/journal.pntd.0007162 – volume: 57 start-page: 748 year: 2017 ident: ref_56 article-title: Harmonization of nucleic acid testing for Zika virus: Development of the 1(st) World Health Organization International Standard publication-title: Transfusion doi: 10.1111/trf.14026 – volume: 113 start-page: 735 year: 2019 ident: ref_50 article-title: Seroprevalence of Zika virus in selected regions in Kenya publication-title: Trans. R. Soc. Trop. Med. Hyg. doi: 10.1093/trstmh/trz077 – volume: 54 start-page: 860 year: 2016 ident: ref_2 article-title: Zika Virus: Diagnostics for an Emerging Pandemic Threat publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.00279-16 – volume: 5 start-page: 1 year: 2013 ident: ref_43 article-title: Dengue viruses exhibit strain-specific infectivity and entry requirements in vitro publication-title: Virus Adapt. Treat. – volume: 536 start-page: 48 year: 2016 ident: ref_44 article-title: Structural basis of potent Zika-dengue virus antibody cross-neutralization publication-title: Nature doi: 10.1038/nature18938 – volume: 100 start-page: 427 year: 2019 ident: ref_3 article-title: Optimizing PCR Detection of Zika Virus from Various Body Fluids publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.18-0755 – volume: 4 start-page: 65 year: 2012 ident: ref_29 article-title: Dengue serotypes 1–4 exhibit unique host specificity in vitro publication-title: Virus Adapt. Treat. doi: 10.2147/VAAT.S36856 – ident: ref_60 doi: 10.1371/journal.pntd.0000721 – ident: ref_14 doi: 10.1371/journal.pntd.0005554 – volume: 152 start-page: 687 year: 2007 ident: ref_18 article-title: Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses publication-title: Arch. Virol. doi: 10.1007/s00705-006-0903-z – volume: 7 start-page: 85 year: 2010 ident: ref_39 article-title: Modeling antibody-enhanced dengue virus infection and disease in mice: Protection or pathogenesis? publication-title: Cell Host Microbe doi: 10.1016/j.chom.2010.02.004 – volume: 83 start-page: 213 year: 1979 ident: ref_19 article-title: Zika virus infections in Nigeria: Virological and seroepidemiological investigations in Oyo State publication-title: J. Hyg. doi: 10.1017/S0022172400025997 – volume: 16 start-page: 1485 year: 2016 ident: ref_46 article-title: Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype publication-title: Cell Rep. doi: 10.1016/j.celrep.2016.07.049 – volume: 68 start-page: 10 year: 2019 ident: ref_47 article-title: Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses publication-title: MMWR Recomm. Rep. doi: 10.15585/mmwr.rr6801a1 – volume: 171 start-page: 229 year: 2017 ident: ref_58 article-title: A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential publication-title: Cell doi: 10.1016/j.cell.2017.09.002 – volume: 353 start-page: 823 year: 2016 ident: ref_33 article-title: Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection publication-title: Science doi: 10.1126/science.aaf8505 – volume: 27 start-page: 974 year: 2019 ident: ref_23 article-title: In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus publication-title: Mol. Ther. J. Am. Soc. Gene Ther. doi: 10.1016/j.ymthe.2019.03.005 – volume: 5 start-page: 137 year: 2005 ident: ref_15 article-title: West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses publication-title: Vector Borne Zoonotic Dis. doi: 10.1089/vbz.2005.5.137 – volume: 19 start-page: E118 year: 2013 ident: ref_16 article-title: Molecular diagnostic and genetic characterization of highly pathogenic viruses: Application during Crimean-Congo haemorrhagic fever virus outbreaks in Eastern Europe and the Middle East publication-title: Clin. Microbiol. Infect. doi: 10.1111/1469-0691.12075 – volume: 75 start-page: 242 year: 2017 ident: ref_54 article-title: Comparison of Zika virus (ZIKV) RNA detection in plasma, whole blood and urine—Case series of travel-associated ZIKV infection imported to Italy, 2016 publication-title: J. Infect. doi: 10.1016/j.jinf.2017.05.021 – volume: 9 start-page: 1391 year: 2018 ident: ref_25 article-title: Performance of the Trioplex real-time RT-PCR assay for detection of Zika, dengue, and chikungunya viruses publication-title: Nat. Commun. doi: 10.1038/s41467-018-03772-1 – volume: 31 start-page: 830 year: 1982 ident: ref_36 article-title: Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.1982.31.830 – volume: 13 start-page: 387 year: 2003 ident: ref_38 article-title: Antibody-dependent enhancement of viral infection: Molecular mechanisms and in vivo implications publication-title: Rev. Med. Virol. doi: 10.1002/rmv.405 – volume: 218 start-page: 536 year: 2018 ident: ref_51 article-title: Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiy164 – volume: 57 start-page: e01506 year: 2018 ident: ref_10 article-title: Comprehensive evaluation of differential serodiagnosis between Zika and dengue viral infection publication-title: J. Clin. Microbiol. – volume: 70 start-page: 37 year: 1989 ident: ref_12 article-title: Antigenic Relationships between Flaviviruses as Determined by Cross-neutralization Tests with Polyclonal Antisera publication-title: J. Gen. Virol. doi: 10.1099/0022-1317-70-1-37 – volume: 19 start-page: 1418 year: 2013 ident: ref_28 article-title: Continued evolution of West Nile virus, Houston, Texas, USA, 2002–2012 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1909.130377 |
| SSID | ssj0001850640 |
| Score | 2.1282642 |
| Snippet | Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref rmit |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1 |
| SubjectTerms | Antibodies cross-reactivity Diagnosis diagnostics flavivirus flavivirus exposure Flaviviruses Genetic aspects Health aspects neutralization Physiological aspects plaque reduction neutralization test Risk factors Serodiagnosis Serology Technique Zika virus Zika virus infection |
| Title | Strain-dependent activity of Zika virus and exposure history in serological diagnostics |
| URI | https://search.informit.org/documentSummary;dn=082954006667958;res=IELHEA https://www.ncbi.nlm.nih.gov/pubmed/32138262 https://www.proquest.com/docview/2374340800 https://pubmed.ncbi.nlm.nih.gov/PMC7157670 https://doaj.org/article/95f0fd17eab347db94435f935a2b2d7a |
| Volume | 5 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9QwFA-yB_EifltdJYLgQYptX9M0x9HdZRHWi64uXkKSJjirdIadDuh_73tJZ2hd0IvXJi35eF-_9OX3GHsJrnKiAZs3AeFqjT4wt1Q1FdWq7YRSsoi8BWcfmtPz-v2FuJiU-qKcsEQPnBbujRKhCF0pvbFQy86qGh18UCBMZatOxtAIfd4ETMXTlUjEVqRbMoC4nlJv1zRt9DECMUhBF1ImnigS9l83yxO_9GfO5OTCffRFJ3fY7TGI5Is0-Lvshu_vsZtn42_y--zLx1j5IT8aK9wOfOFSlQi-Cvzr8rvhn5dX2w03fcePf65XdEzIE2PIL77sOVqQnVHkRykZj-icH7Dzk-NP707zsYJC7kTbDnmAGuqAoEFYcAWABQTSXppOdQF1O_hQY_jXVeDQzlirKhGCE8IgxvHKKgMP2UG_6v1jxg1iaNHa0nkAxISFcVDg6_hFX7oGTMbK3WpqN9KL01x_aIQZtAP6-g5k7PX-nXUi1_hr77e0SfueRIwdH6C46FFc9L_EJWOvaIs1qS8Oz5nxFgJOkoiw9KJBBFpLDGQzdjjriWrnZs0vdkKiqYly1Xq_2m50BRiV1RSJZ-xREpr9mKEizsemypicidNsUvOWfvktsn7LEqGhxG8KEjxNZiIm6_WbSzNs0rqVjU58u9iBLk1jOE74VCrRPvkfq_eU3arovCHm4B2yg-Fq659hUDbY51H_fgNFLDYh |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Strain-Dependent+Activity+of+Zika+Virus+and+Exposure+History+in+Serological+Diagnostics&rft.jtitle=Tropical+medicine+and+infectious+disease&rft.au=Barr%2C+Kelli+L&rft.au=Schwarz%2C+Erika+R&rft.au=Prakoso%2C+Dhani&rft.au=Imtiaz%2C+Kehkashan&rft.date=2020-03-01&rft.issn=2414-6366&rft.eissn=2414-6366&rft.volume=5&rft.issue=1&rft_id=info:doi/10.3390%2Ftropicalmed5010038&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2414-6366&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2414-6366&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2414-6366&client=summon |